What question did this study set out to answer?

To provide recommendations for frontline therapy selection in chronic lymphocytic leukemia based on individual patient characteristics.

December 8, 2025BloodOpen Access

An international view on the current approaches to frontline chronic lymphocytic leukemia therapy

View Full Paper

Ask AI

Bookmark

Authors

Expert recommendations on targeted therapies and patient-centered strategies for CLL, highlighting first-line treatment and molecular profiling.

To provide recommendations for frontline therapy selection in chronic lymphocytic leukemia based on individual patient characteristics.
Panel of 13 hematologists from various global regions discussed CLL treatment strategies.
Focus on patient risk stratification, molecular testing, and treatment preferences.
Evaluation of targeted therapy selection, regimen duration, and molecular profiling.
Emphasis on shared decision-making and patient preferences in therapy selection.
Molecular testing for TP53 mutations is critical for treatment decisions.
First-line therapy recommendations vary based on genetic risk profiles and patient fitness.

Alhuraiji et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025BloodOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Expert recommendations on targeted therapies and patient-centered strategies for CLL, highlighting first-line treatment and molecular profiling.

To provide recommendations for frontline therapy selection in chronic lymphocytic leukemia based on individual patient characteristics.
Panel of 13 hematologists from various global regions discussed CLL treatment strategies.
Focus on patient risk stratification, molecular testing, and treatment preferences.
Evaluation of targeted therapy selection, regimen duration, and molecular profiling.
Emphasis on shared decision-making and patient preferences in therapy selection.
Molecular testing for TP53 mutations is critical for treatment decisions.
First-line therapy recommendations vary based on genetic risk profiles and patient fitness.

Alhuraiji et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark